| scholarly article | Q13442814 |
| P2093 | author name string | Koichi Ishiguro | |
| Shinobu C Fujita | |||
| Fumiko Mukai | |||
| Yumiko Sano | |||
| P2860 | cites work | GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin | Q22253256 |
| Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2 | Q24291461 | ||
| Structure of GSK3beta reveals a primed phosphorylation mechanism | Q27632797 | ||
| Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition | Q27633064 | ||
| Identification of alternative splicing variants of the beta subunit of human Ca(2+)/calmodulin-dependent protein kinase II with different activities | Q28138598 | ||
| A novel tubulin-dependent protein kinase forming a paired helical filament epitope on tau | Q28237004 | ||
| Isolation of MEK5 and differential expression of alternatively spliced forms | Q28285099 | ||
| Casein kinase I alpha and alpha L: alternative splicing-generated kinases exhibit different catalytic properties | Q28568978 | ||
| Alternative pre-mRNA splicing: the logic of combinatorial control | Q29615087 | ||
| The Ste20 group kinases as regulators of MAP kinase cascades | Q29619312 | ||
| The molecular heterogeneity of protein kinase C and its implications for cellular regulation | Q29619947 | ||
| The stress-activated protein kinase subfamily of c-Jun kinases | Q29620001 | ||
| Organization and regulation of mitogen-activated protein kinase signaling pathways | Q33333640 | ||
| Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology | Q34084341 | ||
| Regulation of GSK-3: a cellular multiprocessor | Q34299875 | ||
| Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice | Q34449486 | ||
| Alternative splicing introduces a nuclear localization signal that targets multifunctional CaM kinase to the nucleus | Q36234437 | ||
| In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase | Q36573158 | ||
| Novel Ca2+/calmodulin-dependent protein kinase II gamma-subunit variants expressed in vascular smooth muscle, brain, and cardiomyocytes | Q36851769 | ||
| Signal transduction through beta-catenin and specification of cell fate during embryogenesis | Q38530598 | ||
| The role of protein phosphorylation in the hormonal control of enzyme activity | Q39495926 | ||
| A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation | Q40795858 | ||
| Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling | Q40866028 | ||
| Regulation of alternative splicing of protein kinase C beta by insulin | Q41336389 | ||
| Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. | Q41423732 | ||
| Splicing regulation in neurons: tinkering with cell-specific control | Q41732629 | ||
| Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling | Q42032355 | ||
| wingless signaling acts through zeste-white 3, the Drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fate | Q42121296 | ||
| Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse | Q43664665 | ||
| cDNA cloning of an alternative splicing variant of protein kinase C delta (PKC deltaIII), a new truncated form of PKCdelta, in rats | Q47878773 | ||
| Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology | Q48058842 | ||
| Two types of complementary DNAs of rat brain protein kinase C. Heterogeneity determined by alternative splicing | Q48289247 | ||
| Expression and properties of two types of protein kinase C: alternative splicing from a single gene | Q48344126 | ||
| Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. | Q48394153 | ||
| Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments | Q48395304 | ||
| Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase | Q48406074 | ||
| Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes | Q48603343 | ||
| Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice | Q49050940 | ||
| PHF-tau from Alzheimer's brain comprises four species on SDS-PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase-3 beta. | Q53205825 | ||
| Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. | Q53218504 | ||
| Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. | Q53237934 | ||
| Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. | Q53322724 | ||
| Phosphorylation Sites on Tau Identified by Nanoelectrospray Mass Spectrometry | Q55919559 | ||
| Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals | Q58415331 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | alternative mRNA splicing, via spliceosome | Q21114084 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 1073-1083 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3beta | |
| P478 | volume | 81 |
| Q53331342 | A genome-wide association study of Alzheimer's disease using random forests and enrichment analysis. |
| Q42483831 | Altered cellular distribution of phospho-tau proteins coincides with impaired retrograde axonal transport in neurons of aged rats. |
| Q34336062 | Alternative splicing of the porcine glycogen synthase kinase 3β (GSK-3β) gene with differential expression patterns and regulatory functions |
| Q40029912 | Binding Energy calculation of GSK-3 protein of Human against some anti-diabetic compounds of Momordica charantia linn (Bitter melon). |
| Q39751752 | Binding of BIS like and other ligands with the GSK-3β kinase: a combined docking and MM-PBSA study |
| Q35107567 | Bioinformatic prediction and confirmation of beta-adducin as a novel substrate of glycogen synthase kinase 3. |
| Q35791996 | Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice |
| Q30465622 | Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase |
| Q42135408 | Deconstructing GSK-3: The Fine Regulation of Its Activity |
| Q38989123 | Direct phosphorylation events involved in HIF-α regulation: the role of GSK-3β. |
| Q48895128 | Epigenetic control of somatostatin and cortistatin expression by β amyloid peptide. |
| Q38904991 | Estrogen-related receptor gamma regulates dopaminergic neuronal phenotype by activating GSK3β/NFAT signaling in SH-SY5Y cells |
| Q48279012 | Ether stress-induced Alzheimer-like tau phosphorylation in the normal mouse brain |
| Q37903257 | Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation |
| Q35564819 | Functions of GSK-3 Signaling in Development of the Nervous System. |
| Q21129334 | GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS |
| Q36062876 | GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder |
| Q41816016 | GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction |
| Q30472813 | GSK-3: Functional Insights from Cell Biology and Animal Models |
| Q24624069 | GSK-3: tricks of the trade for a multi-tasking kinase |
| Q48168640 | GSK-3β inhibitor TDZD-8 reduces neonatal hypoxic-ischemic brain injury in mice. |
| Q50757557 | GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis. |
| Q42748129 | GSK3 Function in the Brain during Development, Neuronal Plasticity, and Neurodegeneration |
| Q48226188 | GSK3 alpha and GSK3 beta are necessary for axon formation |
| Q37774552 | GSK3 signalling in neural development |
| Q33702416 | GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity |
| Q35575758 | GSK3β inhibition promotes synaptogenesis in Drosophila and mammalian neurons |
| Q87584187 | GSK3β promotes the differentiation of oligodendrocyte precursor cells via β-catenin-mediated transcriptional regulation |
| Q38155462 | Glycogen synthase kinase 3 beta (GSK3β) at the tip of neuronal development and regeneration |
| Q38645490 | Glycogen synthase kinase 3 in Wnt signaling pathway and cancer |
| Q38116597 | Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia |
| Q24597129 | Glycogen synthase kinase 3: a point of convergence for the host inflammatory response |
| Q36063447 | Glycogen synthase kinase 3: a point of integration in Alzheimer's disease and a therapeutic target? |
| Q24315635 | Glycogen synthase kinase 3: more than a namesake |
| Q38272835 | Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases |
| Q36580561 | Glycogen synthase kinase-3: a potential preventive target for prostate cancer management |
| Q54591455 | Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src. |
| Q37883104 | Glycogen synthase kinase-3β: a mediator of inflammation in Alzheimer's disease? |
| Q26768230 | Hypoxia-Inducible Factors (HIFs) and Phosphorylation: Impact on Stability, Localization, and Transactivity |
| Q54443469 | Identification and analysis of glycogen synthase kinase 3 beta1 interactome. |
| Q36798657 | Identification and characterization of two wheat Glycogen Synthase Kinase 3/ SHAGGY-like kinases |
| Q41447595 | In vivo regulation of glycogen synthase kinase 3β activity in neurons and brains |
| Q37668134 | Increased PKC activity and altered GSK3β/NMDAR function drive behavior cycling in HINT1-deficient mice: bipolarity or opposing forces |
| Q48056810 | Inositol depletion, GSK3 inhibition and bipolar disorder |
| Q38727462 | Lithium in Medicine: Mechanisms of Action |
| Q41444487 | MCK1 is a novel regulator of myo-inositol phosphate synthase (MIPS) that is required for inhibition of inositol synthesis by the mood stabilizer valproate. |
| Q37946881 | Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies |
| Q48146413 | Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases. |
| Q34343577 | Multiple alternative splicing and differential expression pattern of the glycogen synthase kinase-3β (GSK3β) gene in goat (Capra hircus) |
| Q48136087 | N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation |
| Q30442237 | Neurodevelopment in schizophrenia: the role of the wnt pathways |
| Q38149943 | New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease. |
| Q51597974 | Pharmacophore Modeling, Ensemble Docking, Virtual Screening, and Biological Evaluation on Glycogen Synthase Kinase-3β. |
| Q35610595 | Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders |
| Q42032454 | Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma |
| Q36851927 | Rapid Detection of Glycogen Synthase Kinase-3 Activity in Mouse Sperm Using Fluorescent Gel Shift Electrophoresis |
| Q36315309 | Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth. |
| Q41849965 | Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen |
| Q35182182 | Repulsive axon guidance by Draxin is mediated by protein Kinase B (Akt), glycogen synthase kinase-3β (GSK-3β) and microtubule-associated protein 1B. |
| Q36857776 | Role of glycogen synthase kinase-3 in cell fate and epithelial-mesenchymal transitions |
| Q48397790 | Stress-induced hyperphosphorylation of tau in the mouse brain |
| Q30945332 | Synthetic small molecules that control stem cell fate |
| Q57833165 | Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes |
| Q36481069 | Targeting glycogen synthase kinase-3 in insulin signalling |
| Q28854594 | The Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathways |
| Q37035378 | The GSK3 hypothesis of Alzheimer's disease |
| Q26991986 | The regulation and deregulation of Wnt signaling by PARK genes in health and disease |
| Q38166249 | The role of glycogen synthase kinase 3-β in immunity and cell cycle: implications in esophageal cancer |
| Q35035648 | Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease |
| Q38101982 | Understanding the relationship between GSK-3 and Alzheimer's disease: a focus on how GSK-3 can modulate synaptic plasticity processes |
| Q33246692 | Verification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNNB1 and LRP5) and altered Axin-1 expression during tumour progression |
| Q35001234 | What Are the bona fide GSK3 Substrates? |
| Q24597197 | Wnt/beta-catenin signaling and small molecule inhibitors |
Search more.